Tuesday 5 January 2021

• 12:00 - Exosome-Based Therapies for the Treatment Rare Genetic Diseases
  David Lowe (Evox)
  Industry Insight Seminar Series

Tuesday 2 February 2021

• 12:00 - Targeting the Aryl Hyrdrocarbon Receptor (Ahr) as a Novel Immunotherapy for the Treatment of Cancer
  Ilona Gutcher (Bayer AG)
  Industry Insight Seminar Series

Tuesday 2 March 2021

• 12:00 - Transforming the path for equitable access to rapid diagnostics for epidemics
  Joe Fitchett (Mologics)
  Industry Insight Seminar Series

Tuesday 6 April 2021

• 12:00 - Accelerating Covid-19 Antibody Discovery Through Industry-Academia Consortium
  Jane Osbourn OBE, CSO (Alchemab), Paul Kellam, VP infectious diseases and vaccines (Kymab)
  Industry Insight Seminar Series

Tuesday 4 May 2021

• 12:00 - Improving Drug Delivery in Ophthalmology
  Joanna Gould (Founder, Visus-Nano)
  Industry Insight Seminar Series

Tuesday 5 January 2021

• 12:00 - Exosome-Based Therapies for the Treatment Rare Genetic Diseases
  David Lowe (Evox)
  Industry Insight Seminar Series

Tuesday 2 February 2021

• 12:00 - Targeting the Aryl Hyrdrocarbon Receptor (Ahr) as a Novel Immunotherapy for the Treatment of Cancer
  Ilona Gutcher (Bayer AG)
  Industry Insight Seminar Series

Tuesday 2 March 2021

• 12:00 - Transforming the path for equitable access to rapid diagnostics for epidemics
  Joe Fitchett (Mologics)
  Industry Insight Seminar Series

Tuesday 6 April 2021

• 12:00 - Accelerating Covid-19 Antibody Discovery Through Industry-Academia Consortium
  Jane Osbourn OBE, CSO (Alchemab), Paul Kellam, VP infectious diseases and vaccines (Kymab)
  Industry Insight Seminar Series

Tuesday 4 May 2021

• 12:00 - Improving Drug Delivery in Ophthalmology
  Joanna Gould (Founder, Visus-Nano)
  Industry Insight Seminar Series